The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 7.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 24% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (19 analysts) rates it hold, with a mean price target of $125.
CF Industries CF
Clears both ethical standards
An entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.
In plain words · CF Industries Holdings, Inc., together with its subsidiaries, engages in the production of ammonia in North America, Europe, and internationally.
read at $122.92
CF Industries holds its Markup at $122.92.
- PHPhase · the trend structure carries the Markup label
- INInsiders · no filings inside 60 days, left as found
- POPositioning · no disclosures inside 60 days, left as found
- OPOptions · no verdict drawn today, left as found
- SCScreen · passes the values gate
- edge confirmed
- edge broken
- edge forming
Each arm is one independent read. Conviction is not a single call, it is how many edges converge.
The investor read · the season, not the day
| Phase | Markup |
| Quantitative state | The statistical read favours the buyers, held for 6 days |
| Price | $122.92 |
| Valuation | 10.79 trailing · 11.12 forward price to earnings |
| Values screen | PASS · score 83.0 |
| Beta | 0.39 |
The opportunity · what the numbers say it is worth
Our framework reads OPPORTUNITY — it trades above our $107.21 fair value estimate, strong competitive moat, 19.40% revenue growth.
Price history & projections · where it has been, where the models see it going
The valuation journey · where the price sits against fair value and the Street
Green marks levels above today's price, red below; the shaded band is the gap between the price and our fair value.
Reading the gap · Both our model and the Street see limited upside at this price.
| Revenue growth | 19.40% |
| Profit margin | 23.73% |
| Debt to equity | 43.85 |
| Analyst consensus | Hold · 19 covering |
Fair value and rating are our own model estimates; target range reflects third-party analyst estimates. Analysis, not advice.
The values screen, explained · five checks, plain English
This company clears both standards. There are two widely recognised ways to check whether a company is suitable for a Muslim investor. Here is how it did on each:
Used by most halal investing apps ✓ PASSES
The one Titan applies ✓ PASSES
What these two standards are, and how they differ →
- Business activity Its core business isn't built on prohibited lines — no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
- Debt load Interest-bearing debt is just 25.8% of its assets, well under the one-third ceiling — it does not run on borrowed money. Pass
- Interest-bearing cash Cash held in interest-bearing accounts and securities is 0.2% of assets, under the one-third limit. Pass
- Receivables Money owed to the company is 17.2% of assets, under the 49% limit. Pass
- Revenue purity Only 1.1% of revenue comes from non-compliant sources — under the 5% line. Pass
Every security is read against two recognised standards: our stricter asset-based screen (ratios measured against total assets) and the more widely used market-value standard (measured against market capitalisation). Where they agree we say so plainly; where they part ways — almost always on the debt check — we show both readings and mark it, because that disagreement is the finding, not a fault. We report the score; you and your scholar make the call.
The business, in plain words · what the numbers mean
Nitrogen maker looks cheap until the cycle turns
Think of a farmer who buys fertiliser only when rain is late and prices spike. CF Industries sits at the centre of that bet. It carries a strong moat, 24 percent profit margins, 27 percent return on equity and 19 percent revenue growth, all while clearing the ethical screen. The forward multiple of 10.8 times looks attractive next to those returns.
Yet the shares trade 12 percent above our fair value of 107 dollars against a 121 dollar price. In a cyclical industry such numbers often mark peak earnings rather than a bargain. Nineteen analysts sit on hold with a median target near the current level, which tells its own story.
The risk is the classic value trap. When planting slows and inventories build, margins compress fast and the low multiple stops looking cheap. Analysis, not advice.
| Forward P/E | 11.1x cheap for a company growing this fast |
| Trailing P/E | 10.8x reasonably valued |
| Revenue growth | 19.4% steady growth |
| Profit margin | 23.7% healthy profit margins |
| Return on equity | 27.3% an exceptional return on shareholder capital |
| Debt to equity | 0.44 minimal debt — a conservative balance sheet |
| Current ratio | 3.54 comfortably covers its short-term bills |
| Beta | 0.39 barely tracks the market's swings |
| Market cap | $18.9B |
| Employees | 2,900 |
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Latest news · what the market is reading on CF
- › CF Industries Boosts Shareholder Returns With 20% Dividend Hike Zacks · 19d ago
- › Hartford and Amdocs Join the Perfect 10 Portfolio GuruFocus.com · 19d ago
- › Zacks Industry Outlook Nutrien, CF Industries and Yara International Zacks · 19d ago
- › CF Industries Just Raised Its Dividend by 20% While Its Stock Has Surged 55% in 2026 Barchart · 20d ago
- › 3 Fertilizer Stocks to Keep an Eye on in a Challenging Industry Zacks · 20d ago
Headlines from third-party outlets, linked for reference — not our reporting, not advice.
Related securities · others in CF's space worth a look
Screened names in the same industry · explore each on its own page.
Where & how to trade · wherever in the world you are
CF trades on a US exchange. As a US-listed security it is accessible through almost any international broker offering US markets. New to this, or investing from outside the US? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The trader read · the latest dated commentary
The dated journal · newest first, never edited
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 24% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (19 analysts) rates it hold, with a mean price target of $125.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
The insider ledger · Form 4 filings, as filed
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-28 | WHITE CELSO L | Director | 1,390 | · | |
| 2026-04-28 | DEHAAS DEBORAH L. | Director | 1,390 | · | |
| 2026-04-28 | MADRAZO YRIS JESUS | Director | 1,390 | · | |
| 2026-04-28 | NOONAN ANNE P | Director | 2,208 | · | |
| 2026-04-28 | ELLERBUSCH SUSAN A. | Director | 1,390 | · | |
| 2026-04-28 | AHMED JAVED | Director | 1,390 | · | |
| 2026-04-28 | WAGLER THERESA E. | Director | 1,390 | · | |
| 2026-04-28 | TOELLE MICHAEL | Director | 1,390 | · | |
| 2026-04-28 | EAVES JOHN W | Director | 1,390 | · | |
| 2026-04-28 | ARZBAECHER ROBERT C | Director | 1,390 | · |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
The political ledger · congressional disclosures
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 6 Apr2026 | Josh Gottheimer | Democrat | buy | 1K–15K |
| 21 Apr2026 | Susie Lee | Democrat | sell | 1K–15K |
| 16 Jun2026 | Gil Cisneros | Democrat | buy | 1K–15K |
| 15 May2026 | Ro Khanna | Democrat | buy | 1K–15K |
| 15 Apr2026 | Josh Gottheimer | Democrat | buy | 1K–15K |
What holding actually paid · price plus dividends
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $123.97 | -12.5% | $0.50 | $879 | -12.1% |
| 2 months | $120.83 | -10.2% | $0.50 | $902 | -9.8% |
| 3 months | $135.45 | -19.9% | $0.50 | $805 | -19.5% |
| 6 months | $77.92 | +39.2% | $1.00 | $1,405 | +40.5% |
| 1 year | $90.20 | +20.3% | $2.00 | $1,225 | +22.5% |
| 2 years | $75.19 | +44.3% | $4.00 | $1,496 | +49.6% |
| 3 years | $63.46 | +71.0% | $5.80 | $1,801 | +80.1% |
| 5 years | $48.40 | +124.2% | $8.70 | $2,422 | +142.2% |
Historical returns from market close data. Past performance does not guarantee future results.